Imipenem and expression of multidrug efflux pump in Enterobacter aerogenes

Biochemical and Biophysical Research Communications

Volumn 301, Issue 4, 2003, Pages 985-990

  Bornet, Charléric ^a   Chollet, Renaud ^a   Malléa, Monique ^a   Chevalier, Jacqueline ^a   Davin Regli, Anne ^a   Pagès, Jean Marie ^a   Bollet, Claude ^a  

^a AIX MARSEILLE UNIVERSITY   (France)

Author keywords

Efflux pump; Efflux pump inhibitor; Enterobacter aerogenes; Imipenem; Multidrug resistance

Indexed keywords

BACTERIAL PROTEIN; CEFPIROME; CHLORAMPHENICOL; CILASTATIN PLUS IMIPENEM; CIPROFLOXACIN; GENTAMICIN; IMIPENEM; NORFLOXACIN; PORIN; PROTEIN MARA; QUINOLONE DERIVATIVE; TETRACYCLINE; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; CONTROLLED STUDY; ENTEROBACTER AEROGENES; GENE ACTIVATION; GENETIC REGULATION; MEMBRANE PERMEABILITY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ENTEROBACTER; ENTEROBACTER AEROGENES;

EID: 0037459103     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-291X(03)00074-3     Document Type: Article

References (25)

1. Arpin C., Coze C., Rogues A.M., Gachie J.P., Bebear C., Quentin C. Epidemiological study of an outbreak due to multidrug-resistant Enterobacter aerogenes in a medical intensive care unit. J. Clin. Microbiol. 34:1996;2163-2169.
2. Bornet C., Davin-Regli A., Bosi C., Pagès J.-M., Bollet C. Imipenem resistance of Enterobacter aerogenes mediated by outer membrane permeability. J. Clin. Microbiol. 38:2000;1048-1052.
3. Davin-Regli A., Monnet D., Saux P., Bosi C., Charrel R.N., Barthelemy A., Bollet C. Molecular epidemiology of Enterobacter aerogenes acquisition: one-year prospective study in two intensive care units. J. Clin. Microbiol. 34:1996;1474-1480.
4. Jalaluddin S., Devaster J.M., Scheen R., Gerard M., Butlzer J.P. Molecular epidemiological study of nosocomial Enterobacter aerogenes isolates in a Belgian Hospital. J. Clin. Microbiol. 36:1998;1846-1852.
5. Bosi C., Davin-Regli A., Bornet C., Malléa M., Pagès J.-M., Bollet C. Most Enterobacter aerogenes strains in France belong to a prevalent clone. J. Clin. Microbiol. 37:1999;2165-2169.
6. Charrel R.N., Pagès J.-M., De Micco P., Malléa M. Prevalence of outer membrane porin alteration in β-lactam-antibiotic-resistant Enterobacter aerogenes. Antimicrob. Agents Chemother. 40:1996;2854-2858.
7. De Champs C., Henquell C., Guelon D., Sirot D., Gazuy N., Sirot J. Clinical and bacteriological study of nosocomial infections due to Enterobacter aerogenes resistant to imipenem. J. Clin. Microbiol. 31:1993;123-127.
8. De Gheldre Y., Maes N., Rost F., De Ryck R., Clevenbergh P., Vincent J.L., Struelens M.J. Molecular epidemiology of an outbreak of multidrug-resistant Enterobacter aerogenes infections and in vivo emergence of imipenem resistance. J. Clin. Microbiol. 35:1997;152-160.
9. Tzouvelekis L.S., Tzelepi E., Kaufmann M.E., Mentis A.F. Consecutive mutations leading to the emergence in vivo of imipenem resistance in a clinical strain of Enterobacter aerogenes. J. Med. Microbiol. 40:1994;403-407.
10. Hopkins J.M., Towner K.J. Enhanced resistance to cefotaxime and imipenem associated with outer membrane protein alterations in Enterobacter aerogenes. J. Antimicrob. Chemother. 25:1990;49-55.
11. Leying H., Cullmann W., Dick W. Carbapenem resistance in Enterobacter aerogenes is due to lipopolysaccharide alterations. Chemotherapy. 37:1991;106-113.
12. Tzouvelekis L.S., Tzelepi E., Mentis A.F., Vatopoulos A.C., Tsakris C. Imipenem resistance in Enterobacter aerogenes is associated with derepression of chromosomal cephalosporinases and impaired permeability. FEMS Microbiol. Lett. 74:1992;195-200.
13. Malléa M., Chevalier J., Eyraud A., Pagès J.-M. Inhibitors of antibiotic efflux pump in resistant Enterobacter aerogenes strains. Biochem. Biophys. Res. Commun. 293:2002;1370-1373.
14. Malléa M., Chevalier J., Bornet C., Eyraud A., Davin-Regli A., Bollet C., Pagès J.-M. Porin alteration and active efflux: two in vivo drug resistance strategies used by Enterobacter aerogenes. Microbiology. 144:1998;3003-3009.
15. Lomovskaya O., Warren M.S., Lee A., Galazzo J., Fronko R., Lee M., Blais J., Cho D., Chamberland S., Renau T., Leger R., Hecker S., Watkins W., Hoshino K., Ishida H., Lee V.J. Identification and characterization of inhibitors of multidrug resistance efflux pumps in Pseudomonas aeruginosa: novel agents for combination therapy. Antimicrob. Agents Chemother. 45:2001;105-116.
16. Pradel E., Pagès J.-M. The AcrAB-TolC efflux pump contributes to multidrug resistance in the nosocomial pathogen E. aerogenes. Antimicrob. Agents Chemother. 46:2002;2640-2643.
17. Ardanuy C., Linares J., Dominguez M.A., Hernandez-Alles S., Benedi V.J., Martinez-Martinez L. Outer membrane profiles of clonally related Klebsiella pneumoniae isolates from clinical samples and activities of cephalosporins and carbapenems. Antimicrob. Agents Chemother. 42:1998;1636-1640.
18. Goerke C., Campana S., Bayer M.G., Döring G., Botzenhart K., Wolz C. Direct quantitative transcript analysis of the agr regulon of Staphylococcus aureus during human infection in comparisons to the expression profile in vitro. Infect. Immun. 68:2000;1304-1311.
19. Weigel L.M., Stewart C.D., Tenover F.C. gyrA mutations associated with fluoroquinolone resistance in eight species of Enterobacteriaceae. Antimicrob. Agents Chemother. 42:1998;2661-2667.
20. Alekshun M.N., Levy S.B. Regulation of chromosomally mediated multiple antibiotic resistance: the mar regulon. Antimicrob. Agents Chemother. 41:1997;2067-2075.
21. George A.M., Hall R.M., Stokes H.W. Multidrug resistance in Klebsiella pneumoniae: a novel gene, ramA, confers a multidrug resistance phenotype in Escherichia coli. Microbiology. 141:1995;1909-1920.
22. Maneewannakul K., Levy S.B. Identification for mar mutants among quinolone-resistant clinical isolates of Escherichia coli. Antimicrob. Agents Chemother. 40:1996;1695-1698.
23. Webber M.A., Piddock L.J. Absence of mutations in marRAB or soxRS in acrB-overexpressing fluoroquinolone-resistant clinical and veterinary isolates of Escherichia coli. Antimicrob. Agents Chemother. 45:2001;1550-1552.
24. Xiong A., Gottman A., Park C., Baetens M., Pandza S., Matin A. The EmrR protein represses the Escherichia coli emrRAB multidrug resistance operon by directly binding to its promoter region. Antimicrob. Agents Chemother. 44:2000;2905-2907.
25. Chollet R., Bollet C., Chevalier J., Malléa M., Pagès J.-M., Davin-Regli A. mar operon involved in multidrug resistance of Enterobacter aerogenes. Antimicrob. Agents Chemother. 46:2002;1093-1097.